Iranian Red Crescent Medical Journal

Published by: Kowsar
Crossmark

Identification of a Novel Genetic Signature in Staging of Colorectal Cancer: A Bayesian Approach

Fatemeh Mohammadzadeh 1 , Ebrahim Hajizadeh 1 , * , Aliakbar Rasekhi 1 and Sadegh Azimzadeh Jamalkandi 2
Authors Information
1 Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: May 31, 2019, 21 (5); e87526
  • Published Online: June 11, 2019
  • Article Type: Research Article
  • Received: December 14, 2018
  • Revised: March 26, 2019
  • Accepted: April 3, 2019
  • DOI: 10.5812/ircmj.87526

To Cite: Mohammadzadeh F, Hajizadeh E, Rasekhi A, Azimzadeh Jamalkandi S. Identification of a Novel Genetic Signature in Staging of Colorectal Cancer: A Bayesian Approach, Iran Red Crescent Med J. 2019 ; 21(5):e87526. doi: 10.5812/ircmj.87526.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-91. doi: 10.1136/gutjnl-2015-310912. [PubMed: 26818619].
  • 2. Peters U, Bien S, Zubair N. Genetic architecture of colorectal cancer. Gut. 2015;64(10):1623-36. doi: 10.1136/gutjnl-2013-306705. [PubMed: 26187503]. [PubMed Central: PMC4567512].
  • 3. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet. 2005;365(9454):153-65. doi: 10.1016/S0140-6736(05)17706-X. [PubMed: 15639298].
  • 4. Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol. 2003;21(17):3244-8. doi: 10.1200/JCO.2003.03.052. [PubMed: 12947058].
  • 5. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138(3):958-68. doi: 10.1053/j.gastro.2009.11.005. [PubMed: 19914252]. [PubMed Central: PMC3388775].
  • 6. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-64. doi: 10.1093/biostatistics/4.2.249. [PubMed: 12925520].
  • 7. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116-21. doi: 10.1073/pnas.091062498. [PubMed: 11309499]. [PubMed Central: PMC33173].
  • 8. Schwender H. Siggenes: Multiple testing using SAM and Efron’s empirical Bayes approaches. R package version 1.12. 0; 2012.
  • 9. Xu X, Ghosh M. Bayesian variable selection and estimation for group Lasso. Bayesian Anal. 2015;10(4):909-36. doi: 10.1214/14-ba929.
  • 10. Ma S, Song X, Huang J. Supervised group Lasso with applications to microarray data analysis. BMC Bioinformatics. 2007;8:60. doi: 10.1186/1471-2105-8-60. [PubMed: 17316436]. [PubMed Central: PMC1821041].
  • 11. Tibshirani R, Hastie T, Eisen M, Ross D, Botstein D, Brown P. Clustering methods for the analysis of DNA microarray data. Stanford University; 1999.
  • 12. Albert JH, Chib S. Bayesian analysis of binary and polychotomous response data. J Am Stat Assoc. 1993;88(422):669-79. doi: 10.1080/01621459.1993.10476321.
  • 13. Sun X, Wang X, Feng W, Guo H, Tang C, Lu Y, et al. Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer. Oncol Lett. 2017;13(4):2089-96. doi: 10.3892/ol.2017.5691. [PubMed: 28454366]. [PubMed Central: PMC5403337].
  • 14. Qiu Z, Sun W, Gao S, Zhou H, Tan W, Cao M, et al. A 16-gene signature predicting prognosis of patients with oral tongue squamous cell carcinoma. PeerJ. 2017;5. e4062. doi: 10.7717/peerj.4062. [PubMed: 29158988]. [PubMed Central: PMC5695251].
  • 15. Wan YW, Qian Y, Rathnagiriswaran S, Castranova V, Guo NL. A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types. Oncol Rep. 2010;24(2):489-94. doi: 10.3892/or_00000883. [PubMed: 20596637]. [PubMed Central: PMC3095949].
  • 16. Mettu RK, Wan YW, Habermann JK, Ried T, Guo NL. A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types. Int J Biol Markers. 2010;25(4):219-28. [PubMed: 21161944]. [PubMed Central: PMC3155635].
  • 17. Mokarram P, Albokashy M, Zarghooni M, Moosavi MA, Sepehri Z, Chen QM, et al. New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets. Autophagy. 2017;13(5):781-819. doi: 10.1080/15548627.2017.1290751. [PubMed: 28358273]. [PubMed Central: PMC5446063].
  • 18. Nath A, Chan C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers. Sci Rep. 2016;6:18669. doi: 10.1038/srep18669. [PubMed: 26725848]. [PubMed Central: PMC4698658].
  • 19. Crous-Bou M, Rennert G, Cuadras D, Salazar R, Cordero D, Saltz Rennert H, et al. Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer. PLoS One. 2013;8(11). e80158. doi: 10.1371/journal.pone.0080158. [PubMed: 24282520]. [PubMed Central: PMC3839967].
  • 20. Ringrose A, Zhou Y, Pang E, Zhou L, Lin AE, Sheng G, et al. Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas. Leukemia. 2006;20(9):1593-601. doi: 10.1038/sj.leu.2404321. [PubMed: 16838023].
  • 21. Liu W, Guan M, Hu T, Gu X, Lu Y. Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro. PLoS One. 2011;6(8). e24015. doi: 10.1371/journal.pone.0024015. [PubMed: 21918680]. [PubMed Central: PMC3168868].
  • 22. Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, et al. ColoGuideEx: A robust gene classifier specific for stage II colorectal cancer prognosis. Gut. 2012;61(11):1560-7. doi: 10.1136/gutjnl-2011-301179. [PubMed: 22213796].
  • 23. Li J, Zhou C, Ni S, Wang S, Ni C, Yang P, et al. Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer. Oncotarget. 2017;8(56):96249-62. doi: 10.18632/oncotarget.21997. [PubMed: 29221203]. [PubMed Central: PMC5707097].
  • 24. Park HS, Yeo HY, Chang HJ, Kim KH, Park JW, Kim BC, et al. Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer. Yonsei Med J. 2013;54(6):1362-9. doi: 10.3349/ymj.2013.54.6.1362. [PubMed: 24142639]. [PubMed Central: PMC3809881].
  • 25. Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, et al. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford). 2016;2016. doi: 10.1093/database/baw100. [PubMed: 27374120]. [PubMed Central: PMC4930834].
  • 26. Huang Y, Li W, Chu D, Zheng J, Ji G, Li M, et al. Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer. J Gastrointest Surg. 2011;15(7):1188-94. doi: 10.1007/s11605-011-1519-5. [PubMed: 21590459].
  • 27. Ma C, Guo Y, Zhang Y, Duo A, Jia Y, Liu C, et al. PAFAH1B2 is a HIF1a target gene and promotes metastasis in pancreatic cancer. Biochem Biophys Res Commun. 2018;501(3):654-60. doi: 10.1016/j.bbrc.2018.05.039. [PubMed: 29758199].
  • 28. Gutierrez ML, Corchete LA, Sarasquete ME, Del Mar Abad M, Bengoechea O, Ferminan E, et al. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors. Oncotarget. 2017;8(64):107685-700. doi: 10.18632/oncotarget.22591. [PubMed: 29296198]. [PubMed Central: PMC5746100].
  • 29. Magnuson NS, Wang Z, Ding G, Reeves R. Why target PIM1 for cancer diagnosis and treatment? Future Oncol. 2010;6(9):1461-78. doi: 10.2217/fon.10.106. [PubMed: 20919829]. [PubMed Central: PMC3057053].
  • 30. Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010;42(10):874-9. doi: 10.1038/ng.668. [PubMed: 20852632]. [PubMed Central: PMC3020231].
  • 31. Ansari D, Andersson R, Bauden MP, Andersson B, Connolly JB, Welinder C, et al. Protein deep sequencing applied to biobank samples from patients with pancreatic cancer. J Cancer Res Clin Oncol. 2015;141(2):369-80. doi: 10.1007/s00432-014-1817-x. [PubMed: 25216700].
  • 32. Xinying HE, Wang S, Yu LI, Zhang G. Study on the relationship of MiR-2 5 targeting FBXO33 with cell apoptosis and prognosis in renal cell carcinoma. J Mod Lab Med. 2017;32(1):38-40.
  • 33. van de Schoot R, Broere JJ, Perryck KH, Zondervan-Zwijnenburg M, van Loey NE. Analyzing small data sets using Bayesian estimation: The case of posttraumatic stress symptoms following mechanical ventilation in burn survivors. Eur J Psychotraumatol. 2015;6:25216. doi: 10.3402/ejpt.v6.25216. [PubMed: 25765534]. [PubMed Central: PMC4357639].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments